Home arrow HEALTHCARE PRODUCTS
HEALTHCARE PRODUCTS
SunBio PEGylation technology and PEG products have played a crucial role in many successfully marketed biosimilar, biopharmaceutical and medical devices products worldwide.

The healthcare products under development at SunBio are listed in the table.

Category Product/Candidate Status Launch
Biosimilar PEG-filgrastim Biosimilar Marketed 2018 EU
2018 Canada
2008 India
PEG-EPO Biosimilar Preclinical 2023 (forecast)
Medical Device Xerostomia Treatment
(MucoPEG)
2018 FDA filing planned 2019 (forecast)
Viscosupplement for Arthritic Knee
(SynoGEL)
2021 FDA filing planned 2022 (forecast)
Biopharmaceutical Brain Stroke Treatment (SB1) Preclinical 2025 (forecast)
Diabetic Retinopathy Treatment (SB2) Preclinical 2025 (forecast)
Anemia Treatment (SB7) Preclinical 2028 (forecast)
PEG Product PEG Derivatives Manufacture and Sales Marketed Worldwide